<p><b>A.</b> Cumulative survival curves in male patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1 in the age groups of 20 to 49, 50 to 64, and 65 to 74 years of age, respectively. There is no difference of the cumulative risk of ischemic thromboembolism between male AF patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1 for 20 to 49 years of age and overall patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 0. <b>B.</b> Cumulative survival curves in female patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 2 in the age groups of 20 to 49, 50 to 64, and 65 to 74 years of age, respectively. Young female patient with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 2 and 20 to 49 years of age showed significantly higher cumulative risk of clincial event as compared with overall female patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1.</p
